Intravesical Bacillus Calmette-Guerin (BCG) immunotherapy is a proven, effective treatment for intermediate- and high-risk non-muscle-invasive bladder cancer. Minor side effects are common and expected but systemic effects can occur in <5% of treated patients. We present a rare case of a 49-year-old male that presented with fever and chills after 3 weeks of intravesical BCG therapy post transurethral resection of bladder tumor. New renal lesions were present on contrast-enhanced computed tomography scan which was histologically proven to be necrotizing renal granulomatosis.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5939034PMC
http://dx.doi.org/10.4103/jcis.JCIS_83_17DOI Listing

Publication Analysis

Top Keywords

intravesical bacillus
8
bacillus calmette-guerin
8
non-muscle-invasive bladder
8
bladder cancer
8
renal granulomatosis
4
granulomatosis post
4
post intravesical
4
calmette-guerin therapy
4
therapy non-muscle-invasive
4
cancer intravesical
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!